Literature DB >> 11680544

Prevalence of the methylenetetrahydrofolate reductase 677C > T mutation in the Mediterranean Spanish population. Association with cardiovascular risk factors.

M Guillén1, D Corella, O Portolés, J I González, F Mulet, C Sáiz.   

Abstract

Methylenetetrahydrofolate reductase (MT-HFR) is a key enzyme involved in folate metabolism. A common cytosine (C) to a thymine (T) mutation at nucleotide 677 (677C > T) in the MTHFR gene which converts an alanine residue to a valine, has been related with several biochemical phenotypes and with cardiovascular risk, depending on the population studied. Our objective was to estimate the prevalence of the 677C > T mutation in a large and randomly selected sample (289 men and 427 women) from the Mediterranean Spanish population, and to test the association between this genetic variant and some cardiovascular risk factors. For both genders, the prevalence of CC, CT and TT subjects was 32.0, 52.2 and 15.8%, respectively. The frequency (95% confidence interval) of the 677T allele was 0.44 (0.40-0.48) in men and 0.40 (0.37-0.44) in women. This prevalence was significantly different from other European countries, and among the highest reported in the world for any healthy population. We found no association between the 677C > T gene variants and age, body mass index (BMI), total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides or diastolic blood pressure in men and women. However, in men, a statistically significant increase of systolic blood pressure with the number of mutant alleles was found (122.2 mmHg in CC, 125.1 mmHg in CT and 128.5 mmHg in TT subjects; p for trend = 0.030). This association remained significant (p = 0.047) even after adjustment for age, BMI, alcohol consumption, tobacco smoking, education and physical activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11680544     DOI: 10.1023/a:1017978503416

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  39 in total

1.  Methylenetetrahydrofolate reductase genotypes and early-onset coronary artery disease.

Authors:  A Mager; S Lalezari; T Shohat; Y Birnbaum; Y Adler; N Magal; M Shohat
Journal:  Circulation       Date:  1999-12-14       Impact factor: 29.690

2.  Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation.

Authors:  P M Gallagher; R Meleady; D C Shields; K S Tan; D McMaster; R Rozen; A Evans; I M Graham; A S Whitehead
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

3.  The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.

Authors:  M Margaglione; G D'Andrea; M d'Addedda; N Giuliani; G Cappucci; L Iannaccone; G Vecchione; E Grandone; V Brancaccio; G Di Minno
Journal:  Thromb Haemost       Date:  1998-05       Impact factor: 5.249

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

Authors:  N M van der Put; F Gabreëls; E M Stevens; J A Smeitink; F J Trijbels; T K Eskes; L P van den Heuvel; H J Blom
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

Review 6.  Homocysteine and cardiovascular disease: cause or effect?

Authors:  L Brattström; D E Wilcken
Journal:  Am J Clin Nutr       Date:  2000-08       Impact factor: 7.045

Review 7.  The controversy over homocysteine and cardiovascular risk.

Authors:  P M Ueland; H Refsum; S A Beresford; S E Vollset
Journal:  Am J Clin Nutr       Date:  2000-08       Impact factor: 7.045

8.  A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations.

Authors:  G Friedman; N Goldschmidt; Y Friedlander; A Ben-Yehuda; J Selhub; S Babaey; M Mendel; M Kidron; H Bar-On
Journal:  J Nutr       Date:  1999-09       Impact factor: 4.798

9.  The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia.

Authors:  D L Harmon; J V Woodside; J W Yarnell; D McMaster; I S Young; E E McCrum; K F Gey; A S Whitehead; A E Evans
Journal:  QJM       Date:  1996-08

10.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

View more
  3 in total

1.  Factor V Leiden, prothrombin 20210G>A, MTHFR 677C>T and 1298A>C, and homocysteinemia in Tunisian blood donors.

Authors:  Samira Hadhri; Mohamed Ben Rejab; Hajer Guedria; Lamia Ifa; Noureddine Chatti; Hadef Skouri
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

2.  The methylenetetrahydrofolate reductase C677T genotype and the risk of obesity in three large population-based cohorts.

Authors:  Sarah J Lewis; Debbie A Lawlor; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Shah Ebrahim; Jeppe Zacho; Andy Ness; Sam Leary; George Davey Smith
Journal:  Eur J Endocrinol       Date:  2008-04-21       Impact factor: 6.664

3.  Plasma homocysteine in adolescents depends on the interaction between methylenetetrahydrofolate reductase genotype, lipids and folate: a seroepidemiological study.

Authors:  Ruth Gil-Prieto; Valentín Hernández; Beatriz Cano; Manuel Oya; Angel Gil
Journal:  Nutr Metab (Lond)       Date:  2009-10-05       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.